The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners, 5th Edition
This invaluable guide, endorsed by the UKMi and reflecting the extensive experience of the UK Renal Pharmacy Group, features drug monographs guiding physicians in how to prescribe, prepare, and administer drugs to patients with different levels of kidney function and when undergoing renal replacement therapy. It has been fully updated for this fifth edition to include up to 100 additional drugs, while maintaining the clear structure and format that is easy to use and simple to follow in the busy clinical setting. It continues to offer support and guidance to health care professionals enabling them to prescribe medications to their renal patients appropriately and safely.
Отзывы - Написать отзыв
Не удалось найти ни одного отзыва.
Другие издания - Просмотреть все
The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal ...
Caroline Ashley,Aileen Dunleavy
Ограниченный просмотр - 2018
according acid Administration Reconstitution agent amphotericin Antibacterials Anticoagulants Antipsychotics approximately avoid concomitant blood caution CAV/VVHD Important drug Ciclosporin Clinical Comments distribution L/kg Dose in normal Dose in patients Dose in renal drug interactions Potentially elimination Excreted unchanged faeces flecainide fluid flux CAV/VVHD Important give glucose Half-life HD Not dialysed HDF/High flux CAV/VVHD hydrochloride hyperkalaemia impairment GFR mL/min Important drug interactions increased risk infusion interactions Potentially hazardous levels liver mainly metabolites mg daily minutes moclobemide Molecular weight daltons Monitor nephrotoxicity normal renal function normal/ESRF hrs patients undergoing renal Pharmacokinetics plasma possibly increased possibly increased risk possibly reduced Potentially hazardous interactions Protein binding Rate of administration renal impairment GFR renal replacement therapies replacement therapies APD/CAPD response risk of ventricular Route Oral Rate studies therapies APD/CAPD HD toxicity Treatment unchanged in urine undergoing renal replacement Unknown dialysability Unlikely urine Volume ventricular arrhythmias Volume of distribution weeks